Drug Company Illegal Kickbacks and Other Violations of the Anti-Kickback Statute Can Be The Basis of Large Financial Rewards for Whistleblowers Who Properly Expose Kickback Schemes by Drug Company Whistleblower Reward Lawyer Jason S. Coomer
The Anti-Kickback statute prohibits any person or business entity from making or accepting payment to induce or reward any person for referring, recommending or arranging for the purchase of any item or service for which payment may be made under a federally-funded health care program. These federally-funded programs include Medicare and Medicaid. The statute prohibits kickbacks, bribes, inducements, rewards, and other economic incentives that induce physicians to refer patients for services or recommend purchase of medical supplies including drugs that will be reimbursable under government health care programs. For more information on this topic, please go to the following web page: Pharmaceutical Company Illegal Kickback Lawyer Represents Health Care Professionals Expose Illegal Drug Company Kickbacks and Collect Rewards.
Pharmaceutical Professionals, Pharmacists, and Other Health Care Professionals Are Encouraged Through Large Financial Rewards to Expose Drug Company Kickback Schemes
Health Care Whistleblower Reward Lawsuits are the most effective method for identifying and preventing large scale health care fraud against the government. As such, the United States and several states have enacted health care whistleblower reward laws that harness the power of economic incentives by offering large monetary rewards to whistleblowers that properly report significant fraud.
Health care professionals including pharmacists, pharmaceutical professionals, physicians, nurses, hospital administrators, compliance professionals, Medicare coders, and Medicare reimbursement managers can earn large financial rewards for properly exposing drug company kickbacks and other forms of health care fraud. By coming forward and reporting drug company illegal kickbacks, health care professionals can receive large financial rewards based on the amount of money the government can collect from the drug companies. Some past recoveries by the Federal and State Governments have been in the Billions of Dollars while other recoveries have been in the Hundreds of Millions of Dollars. Under the Federal False Claims Act, these whistleblowers or relators can recover 15 to 25 percent of the proceeds of a successful suit, if the United States intervenes in the qui tam action, and up to 30 percent, if the government declines and the relator pursues the action alone.
For more information on this topic, please go to the following web page: Expose Health Care Fraud and Confidential Reviews of Whistleblower Reward Lawsuits and Health Care Fraud Whistleblower Reward Lawsuit Information.